The C6-2B glioma cell line, rich in mitochondrial receptors that bind with high affinity to benzodiazepines, imidazopyridines, and isoquinolinecarboxamides (previously called peripheral-type benzodiazepine receptors), was investigated as a model to study the significance of the polypeptide diazepam binding inhibitor (DBI) and the putative DBI processing products on mitochondrial receptor-regulated steroidogenesis. DBI and its naturally occurring fragments have been found to be present in high concentrations in C6-2B glioma cells, to compete against specific isoquinolinecarboxa- been proposed that glial cells can synthesize steroids de novo (6, 7). In fact, glial cells can convert cholesterol to pregnenolone, which then may be further metabolized to pregnenolone sulfate, 3f3-hydroxy-5-pregnene-20-one, 3/3-hydroxy-5-androstene-17-one, 3a-hydroxy-5a-pregnane-20-one, and 5a-pregnane-3a,21-diol-20-one, which positively or negatively modulate the GABA-gating of Cl-channels (4, 8) .
mide or 4'-chlorodiazepam binding to mitochondrial recognition sites with high affinity, and to stimulate mitochondrial pregnenolone formation. These data suggest that this cell type may express both the receptor and the putative agonist ligand to regulate steroidogenesis. Therefore, we propose to term this mitochondrial receptor MDR (mitochondrial DBI receptor) to indicate its responsiveness to DBI in steroid biosynthesis. In the present work, we show that mitochondria of C6-2B cells convert (22R)-22-hydroxycholesterol to pregnenolone by a mechanism blocked by aminoglutethimide. Immunoblotting confirmed the presence of relatively high levels of cytochrome P-450 cholesterol side-chain-cleavage enzyme in C6-2B cell mitochondria. Furthermore, isoquinolinecarboxamide binding sites associated with the 18-kDa mitochondrial polypeptide subunit of the MDR are abundant in C6-2B glioma cell mitochondria (B 30 pmol/mg protein) and are coupled to the regulation of steroid biosynthesis. Occupancy of MDRs with nanomolar concentrations of the naturally occurring polypeptide, DBI, as well as its naturally occurring processing product tetratriacontaneuropeptide ] increases pregnenolone formation. Clonazepam and octadecaneuropeptide [DBI-(33-50)], which exhibit a higher affinity for r-aminobutyric acid type A receptors but a low affinity for MDR, were ineffective in stimulating pregnenolone synthesis. These findings provide evidence that C6-2B cells exhibit a significant steroidogenic activity which resembles that found in peripheral endocrine organs and they suggest that MDRs and DBI are involved in the regulation of glial cell steroidogenesis.
The specific interactions of steroids with putative membrane binding sites associated with the type A receptor for 'y-aminobutyric acid (GABAA receptor) (1) (2) (3) (4) has prompted a reexamination of the rapid effects of various steroids on neuronal function as well as the investigation of the mechanisms that control the synthesis and release of steroids from cells in the central nervous system. It appears that steroids of peripheral origin can be taken up from the circulation (5) by brain cells, where they bind to specific receptors to form transcription activating factors. In addition, it has recently been proposed that glial cells can synthesize steroids de novo (6, 7) . In fact, glial cells can convert cholesterol to pregnenolone, which then may be further metabolized to pregnenolone sulfate, 3f3-hydroxy-5-pregnene-20-one, 3/3-hydroxy-5-androstene-17-one, 3a-hydroxy-5a-pregnane-20-one, and 5a-pregnane-3a,21-diol-20-one, which positively or negatively modulate the GABA-gating of Cl-channels (4, 8) . Although detailed characterization of this biosynthetic apparatus in glial cells is far from complete, the cytochrome P450 side-chain-cleavage enzyme (P450scc), which participates in steroid biosynthesis by converting cholesterol to pregnenolone, has been identified immunocytochemically in primary glial cultures and in specific rat brain regions (7, 9) .
Two important findings prompted the present investigation: (i) the observations that in adrenal and testis receptors located on the outer membrane of mitochondria and which recognize benzodiazepines, isoquinolinecarboxamides, and imidazopyridines with high affinity-previously defined as peripheral-type benzodiazepine receptors-regulate intramitochondrial cholesterol transport, the rate-limiting step in steroidogenesis (10) (11) (12) , and (ii) the demonstration that diazepam binding inhibitor (DBI), a polypeptide abundant in steroidogenic cells (1, 13, 14) , can stimulate pregnenolone formation in adrenocortical and testicular Leydig cell mitochondria by an interaction with these mitochondrial receptors (15, 16 (17) , competes against the binding of the mitochondrial receptor ligands 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK 11195) and 4'-chlorodiazepam (4'CD) with an affinity comparable to its potency in the steroidogenic effect, it appears to be the natural agonist for the receptor that controls steroidogenesis in glial cells. Therefore, we suggest that this glial mitochondrial receptor be termed MDR (mitochondrial DBI receptor).
METHODS
Cell Culture. The C6-2B subclone of the rat glioma C6 cell line was obtained from Gary Brooker at this institute (18) . 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. medium (GIBCO). Culture dishes (150 mm diameter) were pretreated with 10 ml ofDulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (GIBCO) for 4 hr and washed with phosphate-buffered saline. Cells were then plated and grown in Aim V medium. This procedure did not significantly alter the growth rate of the C6-2B cells compared with their growth in serum-containing media.
Measurement of Mitochondrial Steroid Biosynthesis. Mitochondria from C6-2B cells were prepared as previously described (12) and resuspended at a concentration of 2.0 mg of protein per ml in buffer A (10 mM potassium phosphate buffer, pH 7.0/0.25 M sucrose/5 mM MgCl2/20 mM KCI/15 mM triethanolamine HCI) containing 5 ,uM trilostane (WIN-24540; Sterling-Winthrop Group), an inhibitor of pregnenolone metabolism (11) . Various concentrations of MDR ligands to be tested were then added in buffer A. The mixture was preincubated for 5 min at 370C, and the reaction was started by addition of 15 mM malate (neutralized with 1 M NaOH) and 0. 5 Fig. 2 ). Similar studies were performed using [3H]4'CD (NEN/DuPont) as ligand.
Binding Studies in Hepes at 40C and Photolabeling of MDR. Radioligand binding experiments were performed in 10 mM Hepes, pH 7.4, at 4°C with 10 ,g of mitochondrial protein in a final volume of 400 ,ul. Samples were incubated for 2 hr to attain equilibrium and then filtered as reported before. Photolabeling of C6-2B glial cell MDRs with 10 nM 1-(2-fluoro-
Research Products International) was performed as previously described (11) .
Immunoblot Analyses. Y-1 adrenocortical (12), MA-10
Leydig (11), and C6-2B cells were washed twice with cold phosphate-buffered saline and mitochondria were prepared as previously described (12 (19) . DBI Extraction, Purification, and Assay. DBI was extracted and purified from rat brain as previously described (20) . The purity of the preparations used (>95%) was established by SDS/PAGE, amino acid composition, and chromatographic characteristics on reverse-phase HPLC (14, 20) . DBI-like immunoreactivity of cell extracts was determined by radioimmunoassay (14, 20) . Peptides were synthesized and characterized as previously described (21) . Protein was quantified by using the procedure of Bradford (22) (Fig. 1) . The synthesis of pregnenolone was inhibited by addition of aminoglutethimide, a P-450sCC inhibitor (24) . Glial cell mitochondrial pregnenolone formation was also increased, by 3-to 5-fold, upon addition of either 25- (11, 12, 16 (Fig. 2) . The 18-kDa protein that was purified, sequenced, and shown to be a mitochondrial protein participating in the structure of the isoquinolinecarboxamide and benzodiazepine binding do- mains (25) is identified in both C6-2B and rat adrenal mitochondria by specific covalent labeling with the photoaffinity probe [3H]PK 14105 (Fig. 2 Regulation of Pregnenolone Synthesis in C6-2B Mitochondria by Synthetic and Natural Ligands of MDR. Two MDR synthetic ligands (4'CD and clonazapam) with various affinities for MDR and the natural ligand DBI were tested for their effects on pregnenolone production by C6-2B mitochondrial fractions. The benzodiazepine 4'CD (Fig. 3A) and the 9-kDa polypeptide DBI (Fig. 3A) stimulated pregnenolone synthesis at low nanomolar concentrations with potencies consistent with their abilities to displace [3H]PK 11195 (Fig. 3B) from MDR under the same experimental conditions used to study steroidogenesis.
It is important to note that 4'CD binds with much higher affinity to glial MDRs at 0°C than at 37°C, whereas the affinity of [3H]PK 11195 is virtually unaffected by the temperature and buffer incubation conditions. The time course of the action of maximally stimulated concentrations of DBI and 4'CD on mitochondrial pregnenolone synthesis indicates that the response is virtually linear up to 15 min and a plateau is reached shortly after that time (data not shown). The efficacy of these ligands is linear with concentration from 10-10 to 10-7 M, and it plateaus at 2-3 times the basal level (Fig. 3A) ; however, the efficacy tends to decline for concentrations above 10-6 M. In contrast, the benzodiazepine clonazepam, a structural analogue of 4'CD, which binds with nanomolar affinity to GABAA receptors but fails to bind MDR in concentrations as high as 10-6 M (Fig. 3B) , did not stimulate pregnenolone formation (Fig. 3A) . DBI-like immunoreactivity was found in significant amounts (225 + 20 pmol/mg of protein, n = 3) in C6-2B cell extracts, corresponding to a level 50-fold higher than that required to obtain a maximal steroidogenic response in mitochondrial preparations. The specificity of the steroidogenic effect of DBI was determined by using TTN [DBI-(17-50)] and octadecaneuropeptide [ODN, DBI-(33-50)], two naturally occurring processing products of DBI. TTN, which is known to displace [3H]PK 11195 or [3H]4'CD from glial cells and from brain mitochondria (17, 21, 26) , stimulated C6-2B mitochondrial pregnenolone formation at low nanomolar concentrations (Fig. 4) . In contrast, ODN, which exhibits selectivity for GABAA receptors but low In rat adrenal gland adrenocorticotropin (ACTH), perhaps by means of cAMP production, appears to acutely control DBI processing and chronically control its gene expression (28, 29 
